A systematic review of behavioural therapies for improving swallow and cough function in Parkinson's disease.


Journal

International journal of speech-language pathology
ISSN: 1754-9515
Titre abrégé: Int J Speech Lang Pathol
Pays: England
ID NLM: 101320232

Informations de publication

Date de publication:
Aug 2024
Historique:
medline: 28 8 2024
pubmed: 3 8 2023
entrez: 3 8 2023
Statut: ppublish

Résumé

This systematic review evaluated the efficacy of therapeutic interventions on improving swallow, respiratory, and cough functions in Parkinson's disease (PD). A PRISMA systematic search was implemented across six databases. We selected studies reporting pre- and post-assessment data on the efficacy of behavioural therapies with a swallow or respiratory/cough outcome, and excluded studies on medical/surgical treatments or single-session design. Cross-system outcomes across swallow, respiratory, and cough functions were explored. Cochrane's risk of bias tools were utilised to evaluate study quality. Thirty-six articles were identified and further clustered into four treatment types: swallow related ( Behavioural therapies were diverse in nature and many treatments demonstrated broad cross-system outcome benefits across swallow, respiratory, and cough functions. Given the progressive nature of the condition, the focus of future trials should be evaluating follow-up therapy effects and larger patient populations, including those with more severe disease.

Identifiants

pubmed: 37534927
doi: 10.1080/17549507.2023.2215488
doi:

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

457-474

Auteurs

Shakeela Saleem (S)

School of Psychology, The University of Auckland, Auckland, New Zealand.
Department of Disability Studies, University of Kelaniya, Colombo, Sri Lanka.

Anna Miles (A)

School of Psychology, The University of Auckland, Auckland, New Zealand.

Jacqueline Allen (J)

Department of Surgery, The University of Auckland, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH